BISvsSPTM
ProShares UltraShort Nasdaq Biotechnology against SPDR Portfolio S&P 1500 Composite Stock Market ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BIS | SPTM | |
|---|---|---|
| Expense ratio | 0.95% | 0.030% |
| Assets | $1850.59T | $14B |
| Net flow, 1 month | — | −$41M |
| Net flow, 1 year | +$2K | +$815M |
| Return, YTD | -38.6% | +11.9% |
| Return, 1 year | -53.1% | +14.0% |
| Avg daily volume | 9K | 452K |
| Holdings | 7 | 1510 |
| Listed | Apr 8, 2010 | Oct 3, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS